Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 02, 2015 2:38 AM ET


Company Overview of FORMA Therapeutics, Inc.

Company Overview

FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically-driven diseases. The company’s drug discovery engine deploys screening and structure-based approaches across various families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. It has a strategic partnership with Celgene Corporation. FORMA Therapeutics, Inc. was formerly known as Forma Pharmaceuticals, Inc. and changed its name to FORMA Therapeutics, Inc. in February 2008. The company was incorporated in 2007 and is based in Watertown, Massachusetts and has additional chemistry operations in Branford, Connecticut. FORMA Therapeutics, Inc. operat...

500 Arsenal Street

Suite 100

Watertown, MA 02472

United States

Founded in 2007





Key Executives for FORMA Therapeutics, Inc.

Co-Founder, Chief Executive Officer, President and Director
Co-Founder and Director
Chief Financial Officer
Head of Biomolecular Screening and Executive Director
Chief Business Officer
Compensation as of Fiscal Year 2015.

FORMA Therapeutics, Inc. Key Developments

Forma Therapeutics Appoints John Hohneker, M.D., as Executive Vice President, Head of Research and Development

FORMA Therapeutics announced the appointment of John Hohneker, M.D., as Executive Vice President and Head of Research and Development. Most recently he served as Senior Vice President and Global Head of Development for the immunology and dermatology franchise at Novartis Pharmaceuticals Corporation. Dr. Hohneker will be responsible for leading all aspects of the Company’s discovery and development efforts. Previously he also served as Senior Vice President of U.S. Oncology Clinical Development and Medical Affairs where he played a key role in the development, approval, and/or commercialization of several important life-changing products such as Gleevec®, Tasigna®, Zometa®, Afinitor®, and Exjade®.

FORMA Therapeutics, Inc. Presents at Boston CEO Conference, May-26-2015 through May-27-2015

FORMA Therapeutics, Inc. Presents at Boston CEO Conference, May-26-2015 through May-27-2015. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Presentation Date & Speakers: May-26-2015, Steven Tregay, Co-Founder, Chief Executive Officer, President and Director. May-27-2015, Steven Tregay, Co-Founder, Chief Executive Officer, President and Director.

FORMA Therapeutics, Inc. Appoints Paolo Paoletti as a Board of Directors

FORMA Therapeutics announced the appointment of Paolo Paoletti as a Board of Directors. In addition to serving as a director, Dr. Paoletti will also lead FORMA’s Research & Development Committee as its chairperson; in this capacity, his strategic clinical and research insights will be applied to FORMA’s target family drug discovery paradigm. Dr. Paoletti held several executive leadership roles in oncology at GSK, including Head of Oncology R&D Unit, Member of the Executive Board for Portfolio Investment and Chairman of the Oncology Portfolio Board. In his global leadership roles, he maintained the accountability for GSK’s entire oncology business and was responsible for drug discovery from target identification through registration, including product life cycle management and commercial strategy.

Similar Private Companies By Industry

Company Name Region
Arana Therapeutics, Inc. United States
Durata Therapeutics, Inc. United States
MK Stem Cell Inc. United States
Primorigen Biosciences Inc. United States
Dragonfly Sciences, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FORMA Therapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at